danthron has been researched along with Dermatitis Medicamentosa in 4 studies
danthron: structure
chrysazin : A dihydroxyanthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barth, JH | 1 |
| Reshad, H | 1 |
| Darley, CR | 1 |
| Gibson, JR | 1 |
| Verbov, J | 1 |
| Harland, CC | 1 |
| Mortimer, PS | 1 |
| Green, PG | 1 |
| Grattan, CE | 1 |
| Kennedy, CT | 1 |
| Forbes, DR | 1 |
4 other studies available for danthron and Dermatitis Medicamentosa
| Article | Year |
|---|---|
A cutaneous complication of Dorbanex therapy.
Topics: Aged; Anthraquinones; Cathartics; Drug Combinations; Drug Eruptions; Humans; Pigmentation Disorders; | 1984 |
Laxative eruption.
Topics: Aged; Anthraquinones; Cathartics; Drug Eruptions; Humans; Infant | 1984 |
Laxative-induced contact dermatitis.
Topics: Aged; Aged, 80 and over; Anthraquinones; Buttocks; Cathartics; Dermatitis, Contact; Dermatitis, Irri | 1992 |
Patch testing with dithranol and its degradation products.
Topics: Anthralin; Anthraquinones; Drug Eruptions; Humans; Oxidation-Reduction; Patch Tests | 1988 |